Clinical Trial Update: A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring

View source ↗

Summary

This clinical trial update indicates that a study of the safety of Abrocitinib (CIBINQO) in pregnant women and their offspring is currently recruiting for Atopi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Cibinqo (abrocitinib)

Snippet

Sponsor: Pfizer | Conditions: Atopic Dermatitis | Status: RECRUITING